What's in Shanghai Auzone Biological Technology Co., Ltd.'s pipeline?

Shanghai Auzone Biological Technology Co., Ltd. has 6 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with Shanghai Auzone Biological Technology Co., Ltd.'s portfolio?

Top competitors by shared drug class: Addpharma Inc., Ahn-Gook Pharmaceuticals Co.,Ltd, Beijing Minhai Biotechnology Co., Ltd, Biota Scientific Management Pty Ltd, Cocrystal Pharma, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shanghai-auzone-biological-technology-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Shanghai Auzone Biological Technology Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shanghai Auzone Biological Technology Co., Ltd. pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Radicava ORS	Radicava ORS	marketed	Free radical scavenger; antioxidant	Free radicals (hydroxyl radicals); non-selective antioxidant mechanism	Neurology
Radicava	Radicava	marketed		Polyunsaturated fatty acid lipoxygenase ALOX15	Cardiovascular
TTYP01 tablets	TTYP01 tablets	phase 3	SARS-CoV-2 main protease inhibitor	SARS-CoV-2 main protease	Infectious Diseases

Therapeutic area mix

Cardiovascular · 1
Infectious Diseases · 1
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Addpharma Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class
Biota Scientific Management Pty Ltd · 1 shared drug class
Cocrystal Pharma, Inc. · 1 shared drug class
Ethris GmbH · 1 shared drug class
IRCCS San Raffaele · 1 shared drug class
Icahn School of Medicine at Mount Sinai · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shanghai Auzone Biological Technology Co., Ltd.:

Cite this brief

Drug Landscape (2026). Shanghai Auzone Biological Technology Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shanghai-auzone-biological-technology-co-ltd. Accessed 2026-05-17.